Discussing genetic factors in dyslipidemia |
|
|
|
|
Determining 10-year atherosclerotic vascular disease (ASCVD) risk level |
|
|
|
|
Selecting lipid-lowering therapy |
|
|
|
|
Setting lipid targets and adjusting lipid-lowering therapy dosing accordingly |
|
|
|
|
Optimizing the management of patients with diabetes and dyslipidemia |
|
|
|
|